Last reviewed: June 25, 2026
Last updated: June 25, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has revolutionized weight management since its approval for chronic weight loss in 2021, with clinical trials showing average weight reductions of 15-22% over 68 weeks at therapeutic doses. The question of "what dose is right for me" depends on individual factors including baseline weight, metabolic health, and genetic predisposition to GLP-1 responsiveness. PlexusDx delivers compounded semaglutide injection therapy from licensed 503A pharmacies with personalized dosing protocols starting at just $149 per month.
Standard Semaglutide Dosing Protocol for Weight Loss
The typical semaglutide weight loss dosing schedule follows a titration pattern designed to minimize gastrointestinal side effects while reaching therapeutic efficacy. Most patients begin at 0.25 mg injected subcutaneously once weekly, then increase by 0.25 mg increments every 4 weeks until reaching the target maintenance dose of 2.4 mg weekly. This gradual approach allows the body to adapt to the medication while maximizing tolerability and adherence rates.
Research demonstrates that clinical benefit accumulates across the dosing range, with each 0.25 mg increment contributing measurable weight loss improvements. Patients at 0.5 mg typically lose 5-7% body weight, those at 1.0 mg achieve 10-12% reduction, and those reaching 2.4 mg see reductions of 15-22% depending on lifestyle factors. PlexusDx provides access to the full dosing spectrum with flat monthly pricing, ensuring that dose optimization never triggers price increases.
How Individual Factors Influence Your Optimal Semaglutide Dose
Not all patients respond identically to the same semaglutide dose; factors like body composition, baseline metabolic rate, and genetic variations in GLP-1 receptor sensitivity significantly impact individual outcomes. Starting body weight influences the titration speed—heavier patients may tolerate faster escalation, while those with lower baseline weight might reach target dose more gradually. Age, kidney function, and concurrent medications also shape the personalized dosing plan that produces the best safety-to-efficacy ratio.
The PlexusDx Precision Peptide Genetic Test reveals your individual genetic predisposition across 14 metabolic pathways, including your GLP-1 receptor gene variant (rs6923761) and other peptide-responsive markers. Patients with certain genetic profiles demonstrate enhanced responsiveness to lower semaglutide doses, potentially achieving target weight loss at 1.7 mg rather than 2.4 mg. This personalization transforms dosing from a one-size-fits-all protocol into a precision strategy tailored to your biology, available through PlexusDx's $99 add-on genetic testing after your first month of treatment.
Semaglutide Injection vs. Oral: Which Dosing Strategy Works Better?
Semaglutide injection achieves higher bioavailability than oral formulations, meaning patients typically reach effective weight loss at lower weekly doses via injection. The injectable form delivers medication directly into subcutaneous tissue, bypassing first-pass hepatic metabolism and achieving peak concentrations 1-3 days after injection. Oral semaglutide requires much higher doses (14 mg daily) to achieve comparable blood levels, making injection the more dose-efficient approach for many patients seeking maximum efficacy.
PlexusDx offers both compounded semaglutide injection starting at $149/mo and oral semaglutide at $249/mo, allowing you to choose based on preference and clinical response. Injection patients typically progress through the standard 0.25 mg weekly titration schedule, while oral patients follow a daily escalation beginning at 3 mg. Both routes show robust weight loss efficacy in clinical practice; the choice depends on injection comfort, adherence patterns, and individual gastrointestinal tolerance profiles.
Managing Dose Adjustments and Plateaus During Treatment
Weight loss plateaus occur when the body adapts to a stable semaglutide dose, typically appearing after 12-16 weeks of consistent dosing at a particular level. When progress stalls, dose escalation remains the evidence-based strategy—increasing from 1.7 mg to 2.0 mg or from 2.0 mg to 2.4 mg mg often reignites weight loss momentum. PlexusDx monitors your progress with guidance on when dose adjustments make clinical sense, and critically, your price stays at the same flat monthly rate whether you're taking 0.25 mg or 2.4 mg.
Some patients benefit from temporarily pausing at intermediate doses (1.0 mg or 1.7 mg) to consolidate weight loss and allow metabolic adaptation before advancing further. Others reach their target weight loss at doses lower than 2.4 mg and maintain excellent results on a sustainable maintenance dose. Your PlexusDx provider evaluates monthly progress reports and works with you to determine whether titration should continue, pause, or adjust based on your specific response pattern and lifestyle stability.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What dose of semaglutide should I start with for weight loss?
PlexusDx initiates semaglutide therapy at 0.25 mg subcutaneous injection once weekly, the standard evidence-based starting dose that minimizes side effects. Your dose increases by 0.25 mg every 4 weeks unless you experience intolerable symptoms or reach your target weight loss at a lower maintenance dose. The flat $149/mo pricing applies regardless of your current dose, so optimization never costs more.
What semaglutide dose produces the most weight loss?
Clinical trials show that 2.4 mg weekly semaglutide injection produces the maximum average weight loss of 15-22% over 68 weeks. However, individual results vary based on genetics, lifestyle, and metabolic factors—some patients achieve their goal at 1.7 mg or 2.0 mg with excellent durability. PlexusDx's Precision Peptide Genetic Test helps predict your likely dose-response curve by analyzing your GLP-1 receptor sensitivity and related metabolic genes.
How quickly does semaglutide dosing work for weight loss?
Weight loss typically becomes measurable by week 3-4 of treatment, with the most significant losses appearing between weeks 8-16 as you reach higher maintenance doses. Each 0.25 mg dose increment contributes cumulative weight loss; patients report appetite suppression within days of reaching each new level. PlexusDx tracks your weekly progress and adjusts titration timing based on your individual response rate and tolerability.
Can I stay on a lower semaglutide dose if it's working for me?
Absolutely—if you achieve satisfying weight loss and metabolic improvements at 1.0 mg or 1.7 mg, there is no clinical requirement to escalate further. Some patients find that lower maintenance doses produce sustained weight loss with fewer side effects and better long-term adherence. PlexusDx supports your individualized dosing target, and your monthly cost remains at $149 whether you maintain 1.0 mg or advance to 2.4 mg.
Does the Precision Peptide Genetic Test predict my best semaglutide dose?
Yes—the PlexusDx Precision Peptide Genetic Test analyzes your GLP1R rs6923761 variant and 48 other peptide-related genes across 14 pathways, revealing whether you likely respond more efficiently to lower doses or require higher levels for optimal effect. Patients with enhanced GLP-1 receptor genetic function may achieve 20% weight loss at 1.7 mg instead of 2.4 mg, personalizing your treatment plan. The genetic test costs $99 as an add-on after your first treatment month and serves all 50 states.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Digestive Health: Can You Take Laxatives While on Wegovy?
Can You Stop Taking Mounjaro Anytime?